PLXP PLx Pharma Inc.

PLx Pharma Inc is a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard delivery system to provide safer and more effective aspirin products.

As of 05/12/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  03/13/2014
Outstanding shares:  22,840,078
Average volume:  143,710
Market cap:   $221,320,356
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    72942A107
ISIN:        US72942A1079
Sedol:      BYYCCS1
Valuation   (See tab for details)
PE ratio:   -45.91
PB ratio:   -6.46
PS ratio:   0.00
Return on equity:   139.14%
Net income %:   -49,985.72%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy